Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dolutegravir Monotherapy for HIV (DOMONO)
NCT02401828Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- Mar 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dolutegravir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Erasmus MC. Started Mar 2015; status: completed.
02
Drugs
dolutegravir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02401828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02401828.